PL1727555T3 - Wytwarzanie ekstraktów chmielowych o biologicznym działaniu estrogennym i antyproliferacyjnym - Google Patents

Wytwarzanie ekstraktów chmielowych o biologicznym działaniu estrogennym i antyproliferacyjnym

Info

Publication number
PL1727555T3
PL1727555T3 PL04802152T PL04802152T PL1727555T3 PL 1727555 T3 PL1727555 T3 PL 1727555T3 PL 04802152 T PL04802152 T PL 04802152T PL 04802152 T PL04802152 T PL 04802152T PL 1727555 T3 PL1727555 T3 PL 1727555T3
Authority
PL
Poland
Prior art keywords
production
estrogenic
biological
antiproliferative effects
hop extracts
Prior art date
Application number
PL04802152T
Other languages
English (en)
Inventor
Francis Maes
Keukeleire Denis De
Arne Heyerick
Original Assignee
Metagenics Belgium Bvba
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Metagenics Belgium Bvba filed Critical Metagenics Belgium Bvba
Publication of PL1727555T3 publication Critical patent/PL1727555T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/348—Cannabaceae
    • A61K36/3486—Humulus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32—Antioestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Mycology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Psychiatry (AREA)
  • Vascular Medicine (AREA)
  • Reproductive Health (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicines Containing Plant Substances (AREA)
PL04802152T 2003-12-16 2004-12-15 Wytwarzanie ekstraktów chmielowych o biologicznym działaniu estrogennym i antyproliferacyjnym PL1727555T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP03447290A EP1543834A1 (en) 2003-12-16 2003-12-16 Production of hop extracts having oestrogenic and antiproliferative bioactivity
EP04802152A EP1727555B1 (en) 2003-12-16 2004-12-15 Production of hop extracts having oestrogenic and antiproliferative bioactivity
PCT/BE2004/000176 WO2005058336A1 (en) 2003-12-16 2004-12-15 Production of hop extracts having oestrogenic and antiproliferative bioactivity

Publications (1)

Publication Number Publication Date
PL1727555T3 true PL1727555T3 (pl) 2009-10-30

Family

ID=34486584

Family Applications (1)

Application Number Title Priority Date Filing Date
PL04802152T PL1727555T3 (pl) 2003-12-16 2004-12-15 Wytwarzanie ekstraktów chmielowych o biologicznym działaniu estrogennym i antyproliferacyjnym

Country Status (18)

Country Link
US (2) US20070110835A1 (pl)
EP (2) EP1543834A1 (pl)
JP (2) JP5606660B2 (pl)
CN (1) CN1893963B (pl)
AT (1) ATE429924T1 (pl)
AU (1) AU2004298294B2 (pl)
CA (1) CA2549662C (pl)
DE (1) DE602004020930D1 (pl)
DK (1) DK1727555T3 (pl)
ES (1) ES2326375T3 (pl)
MX (1) MXPA06006782A (pl)
NZ (1) NZ548296A (pl)
PL (1) PL1727555T3 (pl)
PT (1) PT1727555E (pl)
RU (1) RU2370273C2 (pl)
UA (1) UA86607C2 (pl)
WO (1) WO2005058336A1 (pl)
ZA (1) ZA200605478B (pl)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0825506B1 (en) 1996-08-20 2013-03-06 Invensys Systems, Inc. Methods and apparatus for remote process control
US7089530B1 (en) 1999-05-17 2006-08-08 Invensys Systems, Inc. Process control configuration system with connection validation and configuration
WO2000070417A1 (en) * 1999-05-17 2000-11-23 The Foxboro Company Process control configuration system with parameterized objects
US6788980B1 (en) 1999-06-11 2004-09-07 Invensys Systems, Inc. Methods and apparatus for control using control devices that provide a virtual machine environment and that communicate via an IP network
US20040115290A1 (en) 2001-06-20 2004-06-17 Tripp Matthew L. Modulation of inflammation by hops fractions and derivatives
US7901713B2 (en) 2001-06-20 2011-03-08 Metaproteomics, Llc Inhibition of COX-2 and/or 5-LOX activity by fractions isolated or derived from hops
US7901714B2 (en) 2001-06-20 2011-03-08 Metaproteomics, Llp Treatment modalities for autoimmune diseases
US8168234B2 (en) 2001-06-20 2012-05-01 Metaproteomics, Llc Compositions that treat or inhibit pathological conditions associated with inflammatory response
US8142819B2 (en) 2002-10-21 2012-03-27 Metaproteomics, Llc Synergistic compositions that treat or inhibit pathological conditions associated with inflammatory response
US8206753B2 (en) 2001-06-20 2012-06-26 Metaproteomics, Llc Anti-inflammatory botanical products for the treatment of metabolic syndrome and diabetes
US8158160B2 (en) 2001-11-13 2012-04-17 Eric Hauser Kuhrts Anti-inflammatory cyclooxygenase inhibitors
MXPA05004288A (es) 2002-10-21 2005-08-02 Metaproteomics Llc Composiciones para tratar o inhibir los estados patologicos asociados con la respuesta inflamatoria.
US7914831B2 (en) 2004-02-27 2011-03-29 Metaproteomics, Llc Synergistic anti-inflammatory pharmaceutical compositions and related methods using curcuminoids or methylxanthines
NZ555219A (en) * 2004-11-13 2011-03-31 Metaproteomics Llc Compositions exhibiting inhibition of cyclooxygenase-2
DE102005013258B3 (de) * 2005-03-22 2006-10-12 Hopsteiner-Hallertauer Hopfenveredelungsgesellschaft M.B.H. Verfahren zur Herstellung von Naringeninderivaten aus Xanthohumol
AU2012204133B2 (en) * 2005-08-09 2013-09-19 Metaproteomics, Llc Protein kinase modulation by hops and acacia products
CA2618613A1 (en) 2005-08-09 2007-02-22 Metaproteomics, Llc Protein kinase modulation by hops and acacia products
WO2007053915A2 (en) * 2005-11-09 2007-05-18 Universiteit Gent Naringenin derivatives with selectivity on ers
DE102006018988B3 (de) * 2006-04-25 2007-08-09 Nateco2 Gmbh & Co. Kg Verfahren zur Herstellung eines Xanthohumol-haltigen Pulvers hoher Reinheit und dessen Verwendung
EP1958628A1 (en) * 2007-02-16 2008-08-20 KAIROSmed GmbH Combination of immediately liberated drospirenone with a modified releasing formulation containing 8-prenylnaringenin for use in oral contraception and hormone replacement therapy
ATE523202T1 (de) * 2006-11-13 2011-09-15 Nookandeh Baumgaertner Aslieh Dr Extraktionsverfahren zur klassifizierten gewinnung und trennung von pflanzlichen inhaltsstoffen und deren verwendung
WO2008068344A2 (en) * 2006-12-07 2008-06-12 Inbev S.A. Spent hop products, their content in stilbenes and their use as antioxidant for comestible production
DE102006062264A1 (de) 2006-12-22 2008-06-26 Joh. Barth & Sohn Gmbh & Co. Kg Verwendung von Xanthohumol zur Vorbeugung und/oder Bekämpfung von Lebererkrankungen
WO2008140842A1 (en) 2007-05-11 2008-11-20 Metaproteomics, Llc Methods and compositions for heavy metal detoxification
US8142821B2 (en) 2007-08-15 2012-03-27 Flazan GmbH & Co. KG Xanthohumol-enriched hop extract
PL2187899T3 (pl) 2007-08-15 2013-11-29 Flaxan Gmbh & Co Kg Wzbogacony w ksantohumol chmielowy ekstrakt
CN101574398B (zh) * 2008-05-09 2011-04-27 上海信谊百路达药业有限公司 啤酒花提取物及其制备方法与应用
CN104407518B (zh) 2008-06-20 2017-05-31 因文西斯系统公司 对用于过程控制的实际和仿真设施进行交互的系统和方法
FR2940089B1 (fr) * 2008-12-24 2011-03-18 Greenpharma Sas Procede de preparation d'un produit enrichi en flavonoides a partir d'un materiel vegetal
US8127060B2 (en) 2009-05-29 2012-02-28 Invensys Systems, Inc Methods and apparatus for control configuration with control objects that are fieldbus protocol-aware
US8463964B2 (en) 2009-05-29 2013-06-11 Invensys Systems, Inc. Methods and apparatus for control configuration with enhanced change-tracking
EP2392325A1 (en) 2010-06-04 2011-12-07 Universitätsklinikum Münster Compounds for the prevention and/or treatment of osteoarthrosis
CN102115772B (zh) * 2010-12-16 2012-11-14 浙江大学 微生物细胞催化异黄腐酚合成8-异戊烯基柚皮素的方法
CN102911033A (zh) * 2011-08-02 2013-02-06 苏州宝泽堂医药科技有限公司 一种从啤酒花中制备黄腐酚的方法
RU2014108490A (ru) 2011-08-08 2015-09-20 Университет Медычны В Лодзи Полифенольная композиция, ее получение и применение
CN103371989A (zh) * 2012-04-24 2013-10-30 华东师范大学 黄腐酚在制备抑制破骨细胞分化和蚀骨功能的预防和/或治疗药物中的应用
US20150209307A1 (en) * 2012-08-10 2015-07-30 Eric Hauser Kuhrts Compositions and methods for treating mood disorders or skin disease or damage
CN103254054B (zh) * 2013-05-08 2015-03-04 浙江大学 一种具有癌症预防作用的化合物及其制备方法
PL223580B1 (pl) 2013-10-04 2016-10-31 Bioactive Tech Spółka Z Ograniczoną Odpowiedzialnością Sposób otrzymywania ksantohumolu o wysokiej czystości
DE102013017165A1 (de) * 2013-10-16 2015-04-16 Eberhard Karls Universität Tübingen Medizinische Fakultät Zusammensetzung zur Immunmodulation
CZ307451B6 (cs) * 2014-12-16 2018-09-05 Vysoká škola chemicko-technologická v Praze Způsob přípravy chmelového materiálu se zvýšeným obsahem 8-prenylnaringeninu a chmelový materiál
JP2018519342A (ja) 2015-07-02 2018-07-19 フラクサン ゲーエムベーハー ウント コー． カーゲー ホップに基づく物質およびその物質の使用
CN107337661A (zh) * 2016-11-30 2017-11-10 南昌大学 一种从啤酒花中提取8‑异戊二烯基‑4,5,7‑三羟黄烷酮的方法
US10758579B2 (en) 2016-12-07 2020-09-01 Metagreen Ventures Systems and methods for extraction of natural products
PL242648B1 (pl) * 2017-06-30 2023-04-03 Bioactive Tech Spolka Z Ograniczona Odpowiedzialnoscia Sposób otrzymywania ksantohumolu
CN112584826A (zh) 2018-07-30 2021-03-30 联合利华知识产权控股有限公司 包括活性植物成分的组合物
US20210401918A1 (en) * 2018-11-23 2021-12-30 Naturetech Co. Ltd. Composition comprising combination of red clover extract and hops extract for improvement of menopausal disorder
WO2021089840A1 (en) 2019-11-08 2021-05-14 Mrm Health N.V. Fermentation method for the production of phytoestrogens
DK4263781T3 (da) * 2020-12-17 2025-02-24 Heineken Supply Chain Bv Proces til fremstilling af humleekstrakt og en øl med lavt alkoholindhold, der indeholder det samme
KR20240045217A (ko) * 2021-07-09 2024-04-05 이녹스 코포레이션 암을 치료하는 데 사용하기 위한 프레닐화 칼콘 및 플라보노이드 조성물
JP2023153109A (ja) 2022-04-04 2023-10-17 エルジー ハウスホールド アンド ヘルスケア リミテッド ホップ及び白首烏の混合抽出物を有効成分として含む心血管系疾患または骨多孔症の改善用の組成物
CN115650942B (zh) * 2022-10-25 2024-06-04 长沙市惠瑞生物科技有限公司 从啤酒花中提取分离纯化8-异戊烯基柚皮素的方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3607298A (en) * 1967-04-11 1971-09-21 Bush Boake Allen Ltd Hop concentrates
GB1274678A (en) * 1968-11-19 1972-05-17 Bush Boake Allen Ltd Hop extracts
GB1246425A (en) * 1970-03-02 1971-09-15 Pfizer Preparation of hop extract
US3839588A (en) * 1971-07-12 1974-10-01 Commw Scient Ind Res Org Process of preparing hop extracts
GB1423129A (en) * 1971-08-04 1976-01-28 Bush Boake Allen Ltd Isomerised hop extracts
DE2613593A1 (de) * 1975-04-02 1976-10-21 Dev Tech Centre Rech Verfahren zur behandlung von hopfen
DD290661A5 (de) * 1989-12-22 1991-06-06 Veb Wtoez Der Brau- Und Malzindustrie,De Verfahren zur herstellung von vorisomerisiertem hopfenextrakt
DE69320984T2 (de) * 1992-06-04 1999-04-15 S.S. Steiner, Inc., New York, N.Y. Herstellung von isomerisiertem hopfenextrakt
RU2122417C1 (ru) * 1994-09-19 1998-11-27 Игорь Сергеевич Ежов Способ получения изомеризованного экстракта хмеля
JPH09301915A (ja) * 1996-05-08 1997-11-25 Sankyo Co Ltd フラボン及びナフタレン誘導体
JP4374123B2 (ja) * 2000-08-08 2009-12-02 アサマ化成株式会社 食品用防腐剤および食品の防腐方法
AU770436B2 (en) * 2000-09-22 2004-02-19 Unilever Plc Use of prenylated flavones
GB0027769D0 (en) * 2000-11-14 2000-12-27 Unilever Plc Cosmetic method of treating skin
FR2823672B1 (fr) * 2001-04-23 2004-03-12 Berkem Sa Extraits de houblon et leur utilisation dans la preparation d'un medicament ayant des proprietes oestrogenes
DE10139479A1 (de) * 2001-08-10 2003-02-27 Schwabe Willmar Gmbh & Co Hopfenextrakte, Verfahren zu ihrer Herstellung und Verwendung
US7144590B2 (en) * 2003-01-09 2006-12-05 Lipoprotein Technologies, Inc. Bioactive compositions derived from humulus lupulus

Also Published As

Publication number Publication date
EP1727555A1 (en) 2006-12-06
DE602004020930D1 (de) 2009-06-10
AU2004298294A1 (en) 2005-06-30
US20110130447A1 (en) 2011-06-02
PT1727555E (pt) 2009-08-05
ZA200605478B (en) 2009-05-27
MXPA06006782A (es) 2007-01-26
AU2004298294B2 (en) 2011-05-26
RU2006125437A (ru) 2008-01-27
CN1893963A (zh) 2007-01-10
CA2549662A1 (en) 2005-06-30
WO2005058336A1 (en) 2005-06-30
JP5606660B2 (ja) 2014-10-15
EP1543834A1 (en) 2005-06-22
NZ548296A (en) 2009-09-25
ATE429924T1 (de) 2009-05-15
JP2012254085A (ja) 2012-12-27
CN1893963B (zh) 2010-09-29
UA86607C2 (ru) 2009-05-12
DK1727555T3 (da) 2009-08-17
CA2549662C (en) 2014-02-11
ES2326375T3 (es) 2009-10-08
RU2370273C2 (ru) 2009-10-20
US20070110835A1 (en) 2007-05-17
JP2007513982A (ja) 2007-05-31
EP1727555B1 (en) 2009-04-29

Similar Documents

Publication Publication Date Title
PL1727555T3 (pl) Wytwarzanie ekstraktów chmielowych o biologicznym działaniu estrogennym i antyproliferacyjnym
IL181200A0 (en) Natural extract containing xanthohumol, and method for the production thereof and products produced therefrom
ITMI20020632A1 (it) Processo per la preparazione di estratti di pomodoro ad elevato contenuto di licopene
DE60120209D1 (de) Effiziente methode zur herstellung von zusammensetzungen, die mit anthocyaninen angereichert sind
DK1069138T3 (da) Sure proteinfødevareprodukter ved anvendelse af pektiner og fremgangsmåde til fremstilling deraf
DE60114151D1 (de) Extraktion von flavonoiden
WO2002089945A3 (en) Processes and apparatus for extraction of active substances and enriched extracts from natural products
DE60227068D1 (de) Therapeutische verfahren unter verwendung von pflanzlichen zusammensetzungen
DK1628547T3 (da) Oralt snusprodukt og fremgangsmåde til fremstilling deraf
HUP0303002A3 (en) Method for producing an extract from cannabis plant matter, containing a tetrahydrocannabinol and a cannabidiol and cannabis extracts
WO2008011538A3 (en) Methods of using flavonoids to enhance memory
NO20031455L (no) Fremgangsmåte for ekstrahering av forbindelser fra planter
MXPA03008630A (es) Derivados de arilisoxazolinas, procedimientos para su preparacion y su utilizacion como agentes plaguicidas.
PL371319A1 (pl) Pochodne kumaryny, sposób ich wytwarzania i ich zastosowanie
DE60304727D1 (de) Chromatographie-verfahren und vorrichtung welche einen konzentrations-schritt integrieren
UA85691C2 (ru) Твердая ветеринарно-медицинская композиция, содержащая ароматизатор и/или вкусовое вещество
AR024381A1 (es) Procedimiento para obtener plantas con un mayor contenido de flavonoides y compuestos fenolicos
ATE395410T1 (de) Basidiomyzeten, basidiomyzetenextraktzusammensetzung sowie reformkost und immunopotentiatoren
ATE402158T1 (de) Flavonoid-derivat
NO20032633D0 (no) Frö og plante inneholdende vitamin B12 og fremgangsmåte for fremstilling avdenne
UA87114C2 (ru) Способ получения экстракта из листьев плюща, экстракт, его применение и лекарственное средство
MXPA03004537A (es) Derivados sustituidos con ciclohexano y uso de los mismos en medicamentos para tratar enfermedades cardiovasculares.
PL1846412T3 (pl) Sposób wytwarzania 7-etylo-10-hydroksykamptotecyny
DK1450786T3 (da) Isoflavonkoncentrater samt fremgangsmåde til fremstilling deraf
DE602004012104D1 (de) Pflanzenextraktionsverfahren und extrakt